Book a Demo

Please select a preferred date(s) and time(s):

    Contact Sales

      By clicking "Submit" you agree to our Privacy Policy
      INDUSTRY

      Sponsors

      Your mission to drive innovation and bring life-changing treatments to patients aligns with IMC’s commitment to revolutionize adherence-focused technologies.
      sponsors

      Solutions

      Manage Adherence
      manage adherence
      Adherence to a prescribed regimen is crucial for ensuring optimal participant outcomes. Med-ic, eCap, and CertiScan work together to track medication consumption and automatically help participants stay on track. CertiScan can identify aberrant dosing patterns, enabling you to intervene proactively and remotely. We help you support participants in adhering to their treatment plans.
      Make Data-Driven Decisions
      Med-ic and eCap automatically record each dose time without burdening participants. CertiScan stores and centralizes adherence data, providing you with analytics, reports, and insights on-demand, enabling you to monitor trial progress, identify trends, and make proactive decisions.
      Safeguard Trials
      safeguard trials
      The CertiScan Platform can be a critical element in an FDA-mandated risk estimation and mitigation strategy (REMS). With automatic interventions such as mobile smart reminders and targeted educational messages, you can keep participants engaged and adherence levels high. You can also use CertiScan to detect drug misuse, diversion, tampering, and take remote intervention actions.
      Reach Endpoints Sooner
      treatment assessment
      IMC’s solutions streamline data collection, analysis, and intervention, allowing you to reach your endpoints faster and reduce documentation. Analysis of adherence data can help you detect an efficacy signal earlier than otherwise, avoiding unnecessary continuation. The ROI of these measures can be tremendous.

      Learn More about the Products
      that Power our Solutions

      med-ic

      Med-ic®

      The original smart blister package. Breaking a blister records the time and location (i.e. “8:00 a.m.” and “Day 1, Morning”). Med-ic can be customized to work with any blister design and dose pattern.

      eCap™

      The superior smart cap. Unscrewing and removing the eCap records the opening time. Several diameter and threading options are available to fit all common bottle types.

      CertiScan® Platform

      Consumer-quality software for clinical trials. Securely store, analyze, and action the data from smart packaging and other adherence devices. The CertiScan Platform includes web portals, mobile apps, developer tools, and a secure, central cloud.

      ROI

      Our experts have modelled the relationship between statistical power, sample size and medication adherence.
      Their findings? For every 1% adherence increase, there can be a 2% reduction in trial size (N) while holding statistical power constant.
      Considering that many trials currently only reach 50% adherence, there’s lots of room for improvement – and tremendous ROI.
      CRO

      Direct Savings from Reduced N

      Processing a participant is expensive. Requiring a smaller sample size could amount to millions of dollars in savings.
      Drug Development

      Additional Weeks of Patent Protection

      Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.
      enrollment

      Additional Weeks of Patent Protection

      Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.
      Use Cases

      Accurate data for transformative solutions.

      Smart packaging is the ideal data source: it is accurate, automatic, and passive. There is no extra effort on the participant’s part since they were going to take a dose anyways (or not - which smart packaging can also detect!)
      This data feeds into the CertiScan Adherence Platform and other software systems to power numerous solutions.

      Inappropriate medication use is widespread in clinical research. This can harm individual participant outcomes, jeopardize trial outcomes, and cause hidden errors that are only discovered post market or after publishing (such as a poorly titrated dosage or undiscovered side effect).

      Our solutions make it easy to detect and treat these harmful issues. Many protective features are automatic, such as mobile reminders, misuse alerts, targeted coaching.

      Detect and Treat:
      • Medication non-adherence
      • Medication misuse or abuse
      • Temperature exposure and spoilage
      • Expiry
      • Tampering, fraud, and other lot or batch issues

      Shorter trials that reach their endpoints more quickly can gain weeks or months of additional patent protection. This can amount to substantial additional revenue.

      Our solutions help studies reach last dose, last participant sooner.

      Improve timelines by:
      • Automating data collection
      • Replacing diaries and ePRO with smart packaging
      • Letting CertiScan preprocess and analyze data
      • Integrating CertiScan with RTSMs, EDCs, and other platforms
      • Conducting adaptive trials

      Clinical trials are becoming increasingly complex and expensive. Certain activities in a protocol seem straightforward on paper, but in practice can translate into dozens of hours of site work.

      Use our solutions to help eliminate needless overhead and streamline processes.

      Achieve efficiencies and reduce costs by:
      • Automating data collection
      • Basing site inventories on consumption rates
      • Conducting adaptive trials
      • Conducting decentralized trials

      New, technology-first strategies are transforming clinical trials. DCTs, participant diversity initiatives, and AI tools are changing from “nice-to-haves” into “must-haves”.

      Our solutions are modern tools for modern trials that can help researchers and other stakeholders gain and maintain an advantage.

      Adopt CertiScan and smart packaging to:
      • Meet FDA trial modernization guidelines
      • Model PK and PD with adherence data
      • Satisfy internal and external innovation requirements
      • Build accurate, objective datasets for use in AI models, participant diversity initiatives, DCT tools, and more
      • Publish unique studies that stand out in the literaturee

      Recent Articles

      blog
      Press Releases | 6 May 2024

      Information Mediary Corp. and…

      PRESS RELEASE May 6, 2024 – New York, NY — Information Mediary Corp (IMC)…

      Read More
      blog
      Blog | 5 May 2024

      Welcome to the new…

      We are thrilled to unveil our revamped website! As you explore our new digital…

      Read More
      blog
      Case Study | 5 May 2024

      Evaluating Hepatitis C Treatment…

      Overview Direct-Acting Antiviral (DAA) therapy is an effective treatment for hepatitis C. However DAA…

      Read More
      blog
      Scientific Publication | 5 May 2024

      Independent Study finds eCAP…

      Read More
      blog
      Whitepapers | 5 May 2024

      Driving Adherence With Smart…

      Read More
      blog
      Press Releases | 4 May 2024

      IMC introduces CertiScan® 2.0

      Att: Health Tech Desk FOR IMMEDIATE RELEASE April 28, 2021 New York, NY Contact:…

      Read More
      More

      Let's Talk

      Our mission is to create adherence-focused technologies that enable safer, faster, more efficient, and more innovative clinical research. There’s an IMC solution that will transform your next trial. Don’t wait, start the conversation with our team now. We’ll reach out in order to:
      • Deeply understand your particular needs.
      • Explore how Med-ic, eCap, and CertiScan, can benefit your study.
      • Work collaboratively to prepare a specific solution that will exceed your expectations.

      Connect with Us

        By clicking "Submit" you agree to our Privacy Policy